Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.

MLA

Westover, Jonna B., et al. “Low-Dose Ribavirin Potentiates the Antiviral Activity of Favipiravir against Hemorrhagic Fever Viruses.” Antiviral Research, vol. 126, Feb. 2016, pp. 62–68. EBSCOhost, https://doi.org/10.1016/j.antiviral.2015.12.006.

APA

Westover, J. B., Sefing, E. J., Bailey, K. W., Van Wettere, A. J., Jung, K.-H., Dagley, A., Wandersee, L., Downs, B., Smee, D. F., Furuta, Y., Bray, M., & Gowen, B. B. (2016). Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Antiviral Research, 126, 62–68. https://doi.org/10.1016/j.antiviral.2015.12.006

Chicago

Westover, Jonna B, Eric J Sefing, Kevin W Bailey, Arnaud J Van Wettere, Kie-Hoon Jung, Ashley Dagley, Luci Wandersee, et al. 2016. “Low-Dose Ribavirin Potentiates the Antiviral Activity of Favipiravir against Hemorrhagic Fever Viruses.” Antiviral Research 126 (February): 62–68. doi:10.1016/j.antiviral.2015.12.006.